GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Berry Genomics Co Ltd (SZSE:000710) » Definitions » Cyclically Adjusted Revenue per Share

Berry Genomics Co (SZSE:000710) Cyclically Adjusted Revenue per Share : ¥3.76 (As of Sep. 2024)


View and export this data going back to 1997. Start your Free Trial

What is Berry Genomics Co Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Berry Genomics Co's adjusted revenue per share for the three months ended in Sep. 2024 was ¥0.768. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is ¥3.76 for the trailing ten years ended in Sep. 2024.

During the past 12 months, Berry Genomics Co's average Cyclically Adjusted Revenue Growth Rate was 3.30% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 4.50% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 4.40% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was 6.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Berry Genomics Co was 20.30% per year. The lowest was 4.00% per year. And the median was 8.60% per year.

As of today (2025-01-18), Berry Genomics Co's current stock price is ¥8.47. Berry Genomics Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Sep. 2024 was ¥3.76. Berry Genomics Co's Cyclically Adjusted PS Ratio of today is 2.25.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Berry Genomics Co was 28.63. The lowest was 1.73. And the median was 10.23.


Berry Genomics Co Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Berry Genomics Co's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Berry Genomics Co Cyclically Adjusted Revenue per Share Chart

Berry Genomics Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.16 3.21 3.34 3.55 3.66

Berry Genomics Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.64 3.66 3.70 3.70 3.76

Competitive Comparison of Berry Genomics Co's Cyclically Adjusted Revenue per Share

For the Biotechnology subindustry, Berry Genomics Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Berry Genomics Co's Cyclically Adjusted PS Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Berry Genomics Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Berry Genomics Co's Cyclically Adjusted PS Ratio falls into.



Berry Genomics Co Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Berry Genomics Co's adjusted Revenue per Share data for the three months ended in Sep. 2024 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Sep. 2024 (Change)*Current CPI (Sep. 2024)
=0.768/115.7848*115.7848
=0.768

Current CPI (Sep. 2024) = 115.7848.

Berry Genomics Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201412 0.410 99.000 0.480
201503 0.308 99.900 0.357
201506 0.422 99.500 0.491
201509 0.271 100.500 0.312
201512 0.521 100.600 0.600
201603 0.348 102.200 0.394
201606 0.388 101.400 0.443
201609 0.775 102.400 0.876
201612 1.373 102.600 1.549
201703 1.105 103.200 1.240
201706 0.606 103.100 0.681
201709 0.858 104.100 0.954
201712 1.418 104.500 1.571
201803 0.838 105.300 0.921
201806 0.980 104.900 1.082
201809 1.070 106.600 1.162
201812 1.204 106.500 1.309
201903 0.939 107.700 1.009
201906 1.185 107.700 1.274
201909 1.187 109.800 1.252
201912 1.243 111.200 1.294
202003 1.047 112.300 1.079
202006 1.002 110.400 1.051
202009 1.036 111.700 1.074
202012 1.214 111.500 1.261
202103 0.946 112.662 0.972
202106 1.123 111.769 1.163
202109 1.068 112.215 1.102
202112 0.883 113.108 0.904
202203 1.051 114.335 1.064
202206 1.138 114.558 1.150
202209 0.847 115.339 0.850
202212 1.024 115.116 1.030
202303 0.811 115.116 0.816
202306 0.776 114.558 0.784
202309 0.855 115.339 0.858
202312 0.820 114.781 0.827
202403 0.679 115.227 0.682
202406 0.922 114.781 0.930
202409 0.768 115.785 0.768

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Berry Genomics Co  (SZSE:000710) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Berry Genomics Co's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=8.47/3.76
=2.25

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Berry Genomics Co was 28.63. The lowest was 1.73. And the median was 10.23.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Berry Genomics Co Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Berry Genomics Co's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Berry Genomics Co Business Description

Industry
Traded in Other Exchanges
N/A
Address
Life Park Road, Building 5, Courtyard 4, Science and Technology Park, Changping District, Beijing, CHN
Berry Genomics Co Ltd is an innovative biotechnology company. It providess gene sequencing detection equipment and services.
Executives
Gao Yang Directors, executives
Hou Ying Directors, executives
Wang Yu Jing Supervisors
Wang Dong Directors, executives
Zhou Dai Xing Directors, executives
Ou Yang Xiang Yu Supervisors
Li Guang Chao Independent director
Gu Zhong Guo Directors, executives
Wen Wu Director
Ding Xian Xing Supervisors

Berry Genomics Co Headlines

No Headlines